Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Clinical trial NCT06414954 · RECRUITING
Trial details
- NCT number
- NCT06414954
- Sponsor
- NMD Pharma A/S
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-16
- Primary completion
- 2026-12-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.